3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma, Kaposi
1
HIV Infections
1
Acquired Immunodeficiency Syndrome
1
Interventions
Doxorubicin
11
Zidovudine
9
Vincristine
8
Bleomycin
7
Liposomes
5
Interferon alpha-2
5
tecogalan
4
Etoposide
4
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Biopsy
3
sargramostim
2
interferon alfa-n1
2
Semaxinib
2
Rituximab
2
Ritonavir
2
Polymerase Chain Reaction
2
Nivolumab
2
Mitoxantrone
2
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
2
Didanosine
2
Alitretinoin
2
vesnarinone
1
tin etiopurpurin
1
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran
1
pembrolizumab
1
nirogacestat
1
fludarabine phosphate
1
emvododstat
1
efineptakin alfa
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
HIV Infections
×
Emtricitabine
×
Sarcoma
×
Clear all
NCT00444379
2014-08-20
ARKS
University of California, San Francisco
Phase 4
Completed
224 enrolled